Last updated: 30 October 2019 at 5:07pm EST

Life Sciences Ix, L.P.Toppe... Net Worth




The estimated Net Worth of Life Sciences Ix, L.P.Toppe... is at least $136 Millón dollars as of 29 October 2019. Life Toppe owns over 1,052,631 units of Phathom Pharmaceuticals Inc stock worth over $136,215,830 and over the last 5 years Life sold PHAT stock worth over $0.

Life Toppe PHAT stock SEC Form 4 insiders trading

Life has made over 1 trades of the Phathom Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Life bought 1,052,631 units of PHAT stock worth $19,999,989 on 29 October 2019.

The largest trade Life's ever made was buying 1,052,631 units of Phathom Pharmaceuticals Inc stock on 29 October 2019 worth over $19,999,989. On average, Life trades about 1,052,631 units every 0 days since 2019. As of 29 October 2019 Life still owns at least 7,284,269 units of Phathom Pharmaceuticals Inc stock.

You can see the complete history of Life Toppe stock trades at the bottom of the page.



Insiders trading at Phathom Pharmaceuticals Inc

Over the last 5 years, insiders at Phathom Pharmaceuticals Inc have traded over $112,538,769 worth of Phathom Pharmaceuticals Inc stock and bought 2,393,679 units worth $45,337,731 . The most active insiders traders include Capital Management, L.P.Ra ..., James N Topper y Pharmaceutical Co Ltd Takeda. On average, Phathom Pharmaceuticals Inc executives and independent directors trade stock every 24 days with the average trade being worth of $2,226,815. The most recent stock trade was executed by Azmi Nabulsi on 15 July 2024, trading 10,901 units of PHAT stock currently worth $127,760.



What does Phathom Pharmaceuticals Inc do?

phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois.



What does Phathom Pharmaceuticals Inc's logo look like?

Phathom Pharmaceuticals Inc logo

Complete history of Life Toppe stock trades at Phathom Pharmaceuticals Inc

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
29 Oct 2019 Life Sciences Ix, L.P.Toppe...
Comprar 1,052,631 $19.00 $19,999,989
29 Oct 2019
7,284,269


Phathom Pharmaceuticals Inc executives and stock owners

Phathom Pharmaceuticals Inc executives and other stock owners filed with the SEC include: